Clinical study of MaaT03X
Latest Information Update: 21 Jan 2022
At a glance
- Drugs MaaT 03X (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 21 Jan 2022 New trial record
- 17 Jan 2022 According to a MaaT Pharma media release, the company expect to initiate this study in first half of 2023.